Identification and analysis of tumour-associated antigens in hepatocellular carcinoma

British Journal of Cancer

Volumn 92, Issue 5, 2005, Pages 929-934

  Shi, Y Y ^a,b   Wang, H C ^a   Yin, Y H ^a   Sun, W S ^b   Li, Y ^a   Zhang, C Q ^c   Wang, Y ^d   Wang, S ^e   Chen, W F ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANDONG UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^e PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

cDNA microarray; Hepatocellular carcinoma; Serological analysis of recombinant cDNA expression libraries; Tumour antigens

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; CANCER TESTIS ANTIGEN; CELL CYCLE PROTEIN 37; CHAPERONE; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; GALECTIN 4; GALECTIN 8; GENE PRODUCT; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN G; KIAA0379 PROTEIN; MELANOMA ANTIGEN; MESSENGER RNA; MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROGESTERONE INDUCED BLOCKING FACTOR 1; PROTEASOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RIBOSOME PROTEIN 8; SORTING NEXIN 9; SR140 PROTEIN; TRANSGELIN 2; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; COLORECTAL CANCER; COMPLEMENT SYSTEM; CONTROLLED STUDY; DNA MICROARRAY; GENE FUNCTION; HUMAN; HUMAN TISSUE; INTRACELLULAR TRANSPORT; LIVER CELL CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SIGNAL TRANSDUCTION; SPLICEOSOME; STOMACH CANCER; WESTERN BLOTTING;

ANTIGENS, NEOPLASM; CARCINOMA, HEPATOCELLULAR; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 16244421976     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602460     Document Type: Article

References (43)

1. Becker B, Multhoff G, Farkas B, Wild PJ, Landthaler M, Stolz W, Vogt T (2004) Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases. Exp Dermatol 13: 27-32
2. Bidon-Wagner N, Le Pennec JP (2004) Human galectin-8 isoforms and cancer. Glycoconjugation J 19: 557-563
3. Butterfield LH (2004) Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 127: S232-S241
4. Butterfield LH, Ribas A (2002) Immunotherapy of hepatocellular carcinoma. Expert Opin Biol Ther 2: 123-133
5. Butterfield LH, Ribas A, Meng WS, Dissette VB, Amarnani S, Vu HT, Seja E, Todd K, Glaspy JA, McBride WH, Economou JS (2003) T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer. Clin Cancer Res 9: 5902-5908
6. Chen Q, Jackson H, Parente P, Luke T, Rizkalla M, Tai TY, Zhu HC, Mifsud NA, Dimopoulos N, Masterman KA, Hopkins W, Goldie H, Maraskovsky E, Green S, Miloradovic L, McCluskey J, Old LJ, Davis ID, Cebon J, Chen W (2004) Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. Proc Natl Acad Sci USA 101: 9363-9368
7. Cho B, Lee H, Jeong S, Bang YJ, Lee HJ, Hwang KS, Kim HY, Lee YS, Kang GH, Jeoung DI (2003) Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun 307: 52-63
8. Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI (2002) Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 292: 715-726
9. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847
10. Cress WD, Seto E (2000) Histone deacetylases, transcriptional control, and cancer. J Cell Physiol 184: 1-16
11. Davis ID, Chen W, Jackson H, Parente P, Shackleton M, Hopkins W, Chen Q, Dimopoulos N, Luke T, Murphy R, Scott AM, Maraskovsky E, McArthur G, MacGregor D, Sturrock S, Tai TY, Green S, Cuthbertson A, Maher D, Miloradovic L, Mitchell SV, Ritter G, Jungbluth AA, Chen YT, Gnjatic S, Hoffman EW, Old LJ, Cebon JS (2004) Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 101: 10697-10702
12. Huang H, Campbell SC, Nelius T, Bedford DF, Veliceasa D, Bouck NP, Volpert OV (2004a) Alpha 1-antitrypsin inhibits angiogenesis and tumour growth. Int J Cancer 112: 1042-1048
13. Huang JS, Chao CC, Su TL, Yeh SH, Chen DS, Chen CT, Chen PJ, Jou YS (2004b) Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma. Biochem Biophys Res Commun 315: 950-958
14. Huflejt ME, Leffler H (2004) Galectin-4 in normal tissues and cancer. Glycoconjugation J 20: 247-255
15. Iwashita Y, Tahara K, Goto S, Sasaki A, Kai S, Seike M, Chen CL, Kawano K, Kitano S (2003) A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother 52: 155-161
16. Jager E, Gnjatic S, Nagata Y, Stockert E, Jager D, Karbach J, Neumann A, Rieckenberg J, Chen YT, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A (2000) Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc Natl Acad Sci USA 97: 12198-12203
17. Junnikkala S, Jokiranta TS, Friese MA, Jarva H, Zipfel PF, Meri S (2000) Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1. J Immunol 164: 6075-6081
18. Kanai Y, Saito Y, Ushijima S, Hirohashi S (2004) Alterations in gene expression associated with the overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, during human hepatocarcinogenesis. J Cancer Res Clin Oncol 130: 636-644
19. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, Goseki N, Matsubara O, Takenaka K, Shichita M, Tanaka K, Shuda M, Yamamoto M (1999) Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 59: 4990-4996
20. Kruger M, Beger C, Welch PJ, Barber JR, Manns MP, Wong-Staal F (2001) Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation. Mol Cell Biol 21: 8357-8364
21. Kuang M, Peng BG, Lu MD, Liang LJ, Huang JF, He Q, Hua YP, Totsuka S, Liu SQ, Leong KW, Ohno T (2004) Phase II randomized trial of autologous formalin-fixed tumour vaccine for postsurgical recurrence of hepatocellular carcinoma. Clin Cancer Res 10: 1574-1579
22. Lachmann M, Gelbmann D, Kalman E, Polgar B, Buschle M, Von Gabain A, Szekeres-Bartho J, Nagy E (2004) PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome. Int J Cancer 112: 51-60
23. Lee CC, Putnam AJ, Miranti CK, Gustafson M, Wang LM, Vande Woude GF, Gao CF (2004a) Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis. Oncogene 23: 5193-5202
24. Lee SY, Williamson B, Caballero OL, Chen YT, Scanlan MJ, Ritter G, Jongeneel CV, Simpson AJ, Old LJ (2004b) Identification of the gonad-specific anion transporter SLCO6A1 as a cancer/testis (CT) antigen expressed in human lung cancer. Cancer Immun 4: 13
25. Li Y, Lu C, Xing G, Zhu Y, He F (2004) Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell. Exp Cell Res 300: 379-387
26. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96: 9212-9217
27. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC (2003) The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 18: 505-509
28. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652-658
29. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT (2002a) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188: 22-32
30. Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jager D, Jager E, Knuth A, Old LJ (2002b) Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 62: 4041-4047
31. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW (2000) Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285: 194-204
32. Shang XY, Chen HS, Zhang HG, Pang XW, Qiao H, Peng JR, Qin LL, Fei R, Mei MH, Leng XS, Gnjatic S, Ritter G, Simpson AJ, Old LJ, Chen WF (2004) The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients. Clin Cancer Res 10: 6946-6955
33. Shields JM, Rogers-Graham K, Der CJ (2002) Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem 277: 9790-9799
34. Stenner-Liewen F, Luo G, Sahin U, Tureci O, Koslovski M, Kautz I, Liewen H, Pfreundschuh M (2000) Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 9: 285-290
35. Stepanova L, Yang G, DeMayo F, Wheeler TM, Finegold M, Thompson TC, Harper JW (2000) Induction of human Cdc37 in prostate cancer correlates with the ability of targeted Cdc37 expression to promote prostatic hyperplasia. Oncogene 19: 2186-2193
36. Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y (2003) Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Cancer 97: 2474-2479
37. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647
38. Wang HC, Su YR, Han KJ, Pang XW, Peng JR, Liang B, Wang S, Chen WF (2004) Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma. Biochem Cell Biol 82: 321-327
39. Wang X, Seed B (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31: e154
40. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF (2002) Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 169: 1102-1109
41. Wang-Rodriguez J, Dreilinger AD, Alsharabi GM, Rearden A (2002) The signaling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges. Cancer 95: 1387-1395
42. Zhang Z, Torii N, Furusaka A, Malayaman N, Hu Z, Liang TJ (2000) Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem 275: 15157-15165
43. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP, Gottlicher M (2004) Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5: 455-463